Alyeska Investment Group’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-214,300
Closed -$394K 542
2023
Q1
$394K Sell
214,300
-1,250,000
-85% -$2.44M ﹤0.01% 421
2022
Q4
$2.78M Buy
+1,464,300
New +$3.7M 0.03% 299
2021
Q3
Sell
-208,706
Closed -$1.39M 682
2021
Q2
$1.39M Hold
208,706
0.02% 562
2021
Q1
$1.2M Buy
208,706
+42,897
+26% +$318K 0.02% 541
2020
Q4
$1.48M Sell
165,809
-1,327
-0.8% -$14.1K 0.02% 394
2020
Q3
$1.95M Sell
167,136
-101,900
-38% -$1.48M 0.03% 357
2020
Q2
$4.31M Sell
269,036
-37,821
-12% -$419K 0.07% 281
2020
Q1
$1.84M Buy
306,857
+99,546
+48% +$920K 0.04% 264
2019
Q4
$2.74M Buy
207,311
+33,344
+19% +$436K 0.04% 273
2019
Q3
$2.16M Buy
173,967
+75,000
+76% +$991K 0.03% 284
2019
Q2
$1.59M Buy
+98,967
New +$2.21M 0.02% 341
2018
Q4
Sell
-46,500
Closed -$1.43M 365
2018
Q3
$1.43M Sell
46,500
-78,500
-63% -$2.12M 0.02% 325
2018
Q2
$3.35M Buy
+125,000
New +$3.3M 0.03% 307

Other funds holding AUTL